Generics - Pharmaceutical


Current filters:


Popular Filters

176 to 200 of 469 results

EMA focuses on new legislation, increased efficiency and transparency in 2013 work program


The European Medicines Agency has published its work program for 2013. This year, the Agency's priorities…


Hikma delivers revenue growth of 21% and EPS up 24% for 2012


Jordon-headquartered Hikma Pharmaceuticals (LSE: HIK) has reported preliminary results for 2012, showing…

FinancialGenericsHikma PharmaceuticalsPharmaceutical

Experts to examine opportunities in growing African pharmaceutical market


"At a time when growth in traditional pharmaceutical markets is stalling, strong macroeconomic fundamentals…

GenericsMarkets & MarketingPharmaceuticalRegulationRest of the World

Indian Pharma growth outpaces rivals, but must embrace innovation


Ranking among the top five globally by production volume, the Indian pharmaceutical market at present…

Asia-PacificBiotechnologyGenericsMarkets & MarketingPharmaceuticalProductionResearch

Thailand flouts pharmaceutical patent protection; report


Lax enforcement of patent regulations in Thailand is alienating American intellectual property laws,…

Asia-PacificGenericsMarkets & MarketingPatentsPharmaceutical

Further savings expected following Australian Crestor patent decision, says GMiA


In a decision brought down by the Australian Federal Court earlier this week, suppliers of generic medicines…


Par Pharma agrees $45 million settlement over off-label Megace ES promotion


US generic drugmaker Par Pharmaceutical NYSE: PRX) pleaded guilty in federal court yesterday (March 6)…

FinancialGenericsLegalMarkets & MarketingMegace ESMetabolicsNorth AmericaPar PharmaceuticalPharmaceutical

Anti-infective market in sub-Saharan Africa set to reach $377 million in 2018


The high incidence of infectious diseases in sub-Saharan Africa is expected to sustain the demand for…

Antibiotics and Infectious diseasesGenericsMarkets & MarketingPharmaceuticalRest of the World

Indian patent appeal board upholds compulsory license on Bayer's Nexavar


After much delay, the verdict into German pharmaceutical major Bayer's (BAYN: DE) appeal against the…

Asia-PacificBayerGenericsNatco PharmaNexavarOncologyPatentsPharmaceutical

Hikma leaps as it confirms unsolicited interest in Injectables business


Jordanian drugmaker Hikma Pharmaceuticals (LSE: HIK) saw its shares jump 8.1% to£9.365 on Friday,…

FinancialGenericsHikma PharmaceuticalsMergers & AcquisitionsPharmaceutical

New US Federal Trade Commission chairman - Edith Ramirez - to be designated by President


President Barack Obama intends to designate Edith Ramirez as Chairman of the Federal Trade Commission…

BiotechnologyGenericsManagementNorth AmericaPharmaceuticalRegulation

India's Cipla ups bid for Cipla Medpro now seeking 100% control for around $512 million


Indian drugmaker Cipla (BSE: 500087) has made an offer to the shareholders of Cipla Medpro South Africa…

CiplaCipla MedproGenericsMarkets & MarketingPharmaceutical

Russian government to develop domestic production of vaccines


The Russian government is considering investing in the domestic production of vaccines, by building a…


Medicines Patent Pool and ViiV Healthcare collaborate to treat pediatric HIV


The Medicines Patent Pool (MPP) this week announced the launch of a new collaboration with ViiV Healthcare…

AbacavirAnti-viralsGenericsGlobalPatentsPharmaceuticalViiV Healthcare

PHARMAC holding back New Zealand health care industry growth, says GlobalData


Despite disproportionate elderly population growth and an unsaturated market acting as key drivers, growth…

Asia-PacificGenericsMarkets & MarketingPharmaceuticalPricing

Briefs: Ablynx inks research deal with Spirogen; Solent Pharma debuts


Belgium drug developer Ablynx (Euronext Brussels: ABLX]) has entered into a research collaboration with…

AblynxGenericsidebenoneIdecortexLicensingMarkets & MarketingNeurologicalOncologyPharmaceuticalResearchSolent PharmaSpirogen

Australian trade groups argue over how increasing generic drug use drives savings


While there is no difference when it comes to safety, efficacy and quality, there is a difference when…


Indian pharma excipients distributor IndChem acquired by Dutch firm IMCD


Netherlands-based conglomerate IMCD Group BV has acquired the business of IndChem International, an established…

GenericsIMCD GroupIndChemMergers & AcquisitionsPharmaceutical

South African pharma market set to grow to $7 billion in 2018


South Africa's pharmaceutical market is one of the most attractive markets in Africa. Some of the main…

GenericsMarkets & MarketingPharmaceuticalRegulationRest of the World

Ukraine pharma industry appeals to President on some new drug law provisions


Ukraine's Association of Pharmaceutical Research and Development, APRAD, has written to the country's…


Global Pharma may leave Russian market due to protectionist policies


The planned imposition of restrictions for the public purchase of imported drugs, initiated by the Russian…

EuropeGenericsMarkets & MarketingPharmaceuticalPoliticsRegulation

Drugmakers to continue facing growing generic competition in 2013


Last year saw the expiration of patents for several blockbuster drugs, leading to increasing generic…

AmarinFinancialForest LaboratoriesGenericsPatentsPharmaceutical

Merck & Co to pay $688 million to settle investor law suits; Teva could face $2.1 billion damages


US pharma giant Merck & Co (NYSE: MRK) said yesterday that it has reached an agreement in principle with…

FinancialGenericsLegalMerck & CoPharmaceuticalProtonixTeva Pharmaceutical IndustriesVytorinZetia

176 to 200 of 469 results

Back to top